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2012.04.0Abstract A simple, accurate, and rapid extraction spectrophotometric procedure has been devel-
oped for the determination of some phenothiazine drugs such as chlorpromazine hydrochloride
(CPH) and triﬂuoperazine dihydrochloride (TFPH) in pure form and their pharmaceutical prepa-
rations. The procedures are based on the reaction between the examined drugs (CPH and TFPH)
and Alizarin Red S (AR), Bromocresol Purple (BCP), Chlorophenol Red (CPR) and Cresol Red
(CR) producing ion-pair complexes which can be measured at the optimum wavelengths. The opti-
mizations of the reaction conditions were investigated. Beer’s law is obeyed in the concentration
ranges 1.77–96 lg ml1. The molar absorptivity and Sandell sensitivity are also calculated. The cor-
relation coefﬁcient for both drugs wasP0.9995 (n= 5) with a relative standard deviation (R.S.D.)
60.38. The methods are successfully applied to determine CPH and TFPH in pharmaceutical for-
mulations.
ª 2012 Forensic Medicine Authority. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Chlorpromazine hydrochloride (CPH) is 2-chloro-N,N-di-
methyl-10H-phenothiazine-10-propanamine hydrochloride.
Triﬂuoperazine dihydrochloride (TFPH) is 10-[3-(4-methy
l-1-piperazinyl)propyl]-2-(triﬂuoromethyl)-10H-phenothiazine
dihydrochloride.1223861504.
il.com (M.E.M. Hassouna).
g Saud University.
g by Elsevier
uthority. Production and hosting
01They are phenothiazine antipsychotics,1 and are used in the
treatment of a variety of psychiatric2,3 disorders including
schizophrenia, severe anxiety, disturbed behavior, control of
nausea and vomiting. Several methods have been applied for
the determination of triﬂuoperazine hydrochloride and
chlorpromazine hydrochloride in dosage forms and in biologicalby Elsevier B.V. All rights reserved.
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63ﬂuids. The different techniques used in this action include spec-
trophotometry,4–7 H.P.L.C.,8–14 G.C.,15,16 coulometric17 and
electrochemical18 detection and T.L.C.19
In this paper, a study of the determination of some pheno-
thiazine drugs such as CPH and TFPH in pure form and in dif-
ferent pharmaceutical preparations available in the Egyptian
market has been undertaken. The proposed method is based
on the reaction of these drugs with AR, BCP, CPR and CR re-
agents, respectively and extraction of the formed intense yel-
low ion-pairs with chloroform. Different factors affecting
these reactions are studied. The proposed method has the
advantage of being rapid, simple, accurate, economic, sensitive
and less-time consuming.
2. Experimental
2.1. Apparatus
A JASCO 530V spectrophotometer with 10 mm quartz cell
was used for all spectrophotometric measurements, an Orion
research model 601 A/digital ionalyzer was used for checking
the pH of Britton–Robinson (B.R.)20 buffer solutions of pH
values in the range 2.0–12.0 and thermo stated water bath
model Medingen W 20.
2.2. Reagents
Alizarin Red S, dihydroxy-9,10-dioxo-2-anthracene sulfonic
acid (AR), Bromocresol Purple (BCP), 3,4-Chlorophenol
Red (CPR) and Cresol Red , o-cresol sulphonaphthalein
(CR) were Merck products. A stock solution (1 · 103 M)
was prepared by dissolving the appropriate weights of AR in
doubly distilled water, while, BCP, CPR and CR were
dissolved in the least volume of methanol then completed with
bidistilled water. CPH and its pharmaceutical formulation
(viz. Stellasile tablets 5 mg) were supplied by Kahira Pharma
(Egypt). TFPH and its pharmaceutical formulation (viz.
Promacid tablets 100 mg) were supplied by Chemical Indus-
tries Development CID (Egypt). Britton–Robinson buffer
solution20: a stock acid mixture was prepared by mixing equal
volumes of 0.4 M solutions of three acids (phosphoric, acetic
and boric acids). A series of buffer solutions of pH 2–12 were
prepared by adding appropriate volumes of 0.1 M of sodium
hydroxide.Table 1 Characteristics and analytical data of CPH and TFPH ion
Parameters CPH
AR BCP CPR
kmax (nm) 425 399 398
Beer’s law limits (lg/ml) 7.1–78.16 3.55–32 3–35
Molar absorptivity (e) [L mol1 cm1 ] 0.39 · 104 1.29 · 104 1.21
Sandell sensitivity (lg cm2) 0.090 0.027 0.029
Regression equation*
Intercept 0.012 0.007 0.016
Slope 0.011 0.036 0.033
Correlation coeﬃcient 0.9999 0.9995 0.999
* A= a+ bc, where c is the concentration lg/ml.2.3. General procedure
In 100 ml separating funnel, 2.5 ml of (1 · 103 M) of AR,
BCP, CPR or CR were added, different volumes of solution
containing (1 · 103 M) of the drugs CPH or TFPH were
added, then 4 ml of pH 3 buffer, and the volume was made
up to 10 ml with bidistilled water. The yellow formed ion-pair
was extracted with 10 ml chloroform by shaking for 2 min and
allowing to separate into two layers. The organic layer was
collected and dried by passage through Whatman ﬁlter paper
No. 1 previously washed with chloroform then complete to
10 ml with the same solvent. The absorbance of the extract
was measured at the recommended wavelength against a blank
treated in the same way (Table 1). All measurements were
carried out at room temperature (25 ± 2 C).
2.3.1. Application to various dosage forms
At least 10 tablets of the drug were weighed into a small dish,
powdered and mixed well. A portion equivalent to 100 mg was
weighed and dissolved in 100 ml water, shaken well and ﬁltered
through a Whatman ﬁlter paper No. 1. The clear solution was
diluted with bidistilled water to the mark in a 250 ml calibrated
ﬂask. The drug content of an aliquot of this solution was ob-
tained by applying the general procedure as described above.
2.4. Stoichiometric relationship
Job’s method of continuous variation was employed, using
(1 · 103 M) standard solution of CPH and TFPH and of
(1 · 103 M) solution of the reagents (AR, BCP, CPR or
CR) were used. In 100 ml separating funnel a series of solu-
tions were prepared in which the total volume of drug and re-
agent was kept constant at 1 ml .To these solutions 4 ml buffer
(pH 3) and 5 ml bidistilled water were added and extraction
was carried out with 10 ml chloroform. The latter extract
was treated as previously illustrated and its absorbance was
measured as usual.
3. Results and discussion
This work is undertaken in the view that, ion-pairs are formed
between tertiary amino group of CPH and TFPH drugs and of
AR, BCP, CPR or CR reagents via the protonated nitrogen
atom of the drugs. The formed ion-pairs are soluble in-pair with (AR, BCP, CPR and CR) reagents.
TFPH
CR AR BCP CPR CR
396 424 399 398 394
1.77–28.4 10–96 4–28 9–48 2–44
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Figure 2 Effect of Alizarin Red S (AR), Bromocresol Purple
(BCP), Chlorophenol Red (CPR) and Cresol Red (CR) concen-
trations on triﬂuoperazine dihydrochloride (TFPH).
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Figure 3 Effect of temperature on the stability of CPH-ion pairs
with AR, BCP, CPR and CR.
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64 M.E.M. Hassouna et al.chloroform. Several parameters such as reagent concentration,
sequence of addition, type of extracting solvent, effect of pH,
effect of time and temperature were optimized to achieve the
highest sensitivity, stability and reproducibility of results.
3.1. Optimization
Most favorable conditions were examined to achieve maximum
color intensity in the quantitative determination of the
examined drugs (CPH and TFPH). The absorption spectra of
CPH and TFPH and their ion-pairs with Alizarin Red S,
Bromocresol Purple, Chlorophenol Red and Cresol Red under
the optimum conditions are recorded in Table 1. The absorp-
tion band of CPH and TFPH ion-pairs are located at 425,
399, 398 and 396 nm, 424, 399, 398 and 394 nm with the
reagents AR, BCP, CPR and CR, respectively. However, in
all instances, the absorbance was measured at the correspond-
ing kmax against a reagent blank; the inﬂuence of each of the
following variables on the reaction was tested.
3.1.1. Effect of the type of the extracting solvent
The polarity of the solvent affects both extracting efﬁciency
and absorptivity of the ion-pair. Various water-immiscible
organic solvents were tested (viz. methylene chloride, chloro-
form, benzene, n-hexane, cyclohexane, ethyl acetate, petro-
leum ether and toluene). The most convenient solvent found
to develop the maximum color intensity and extracting power
of ion-pair was chloroform for both drugs CPH and TFPH.
Although, it is a toxic solvent, it has been used cautiously.
The study revealed that a volume ratio of 1:1 (aque-
ous:organic) phases was the most suitable for the ion-pair
extraction.
3.1.2. Effect of the reagent concentration
The effect of reagents was investigated by taking various
amounts (0.5–5.0 ml) of 1 · 103 M of reagents (AR, BCP,
CPR or CR) and an aliquot of a solution containing
20 lg ml1 of each of the two investigated drugs. It was found
that the maximum absorbance was observed with the addition
of 2.5 ml of each of reagents with each drug, beyond these vol-
umes the absorbance remained constant (Figs. 1 and 2).0 1 2 3 4 5 6
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Figure 1 Effect of Alizarin Red S (AR), Bromocresol Purple
(BCP), Chlorophenol Red (CPR) and Cresol Red (CR) concen-
trations on chlorpromazine hydrochloride CPH.
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Figure 4 Effect of temperature on the stability of TFPH-ion
pairs with AR, BCP, CPR and CR.3.1.3. Effect of pH
The effect of pH on the formation of the ion-pairs in the pres-
ence of 20 lg ml1 of CPH or TFPH drugs was studied by
using a series of Britton–Robinson (BR) buffer solutions in
the range of pH 2–12. Applying the same procedure, pH 3
was selected as optimum and the optimum volume of buffer
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Figure 8 The molar ratio of TFPH ion-pairs with reagents AR,
BCP, CPR and CR.
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Figure 5 Effect of time on the stability of CPH-ion pairs with
AR, BCP, CPR and CR.
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Figure 6 Effect of time on the stability of TFPH-ion pairs with
AR, BCP, CPR and CR.
0.0 0.2 0.4 0.6 0.8 1.0 1.2 1.4 1.6 1.8 2.0 2.2
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
 BCP
 CPR
 AR
 CR
A
bs
or
ba
nc
e
Molar ratio (D)/(R)
Figure 7 The molar ratio of CPH ion-pairs with reagents AR,
BCP, CPR and CR.
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Figure 10 Continuous variation of TFPH ion-pairs with
reagents AR, BCP, CPR and CR.
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Figure 9 Continuous variation of CPH ion-pairs with reagents
AR, BCP, CPR and CR.
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65to be included in 10 ml aqueous phase that giving constant
absorbance value was found to be 4.0 ml.
3.1.4. Effect of temperature
The effect of temperature on the formation and stability of ion-
pair was studied by measuring the absorbance of the extracted
ion-pair in the temperature range 25–100 C. The results show
that the ion-pairs were formed almost instantaneously at roomtemperature (25 ± 2 C) and remain constant up to 60 C for
all reagents (Figs. 3 and 4).
3.1.5. Effect of time
The effect of time was studied by measuring the absorbance of
the extracted ion-pairs at increasing time intervals. The results
show that the developed color remained stable for 18 h. With
all reagents, beyond 18 h slight decrease in color intensity oc-
curred. (Figs. 5 and 6).
Table 2 Evaluation of accuracy of the proposed method for the determination of CPH and TFPH.
Ion-pairs Pure solution (lg/ml) Tablets (lg/ml)
Taken Found Recovery % Taken Found Recovery %
CPH-AR 20 19.9 99.66 20 19.9 99.38
30 30.1 100.25 30 30.1 100.50
40 40 100 40 39.7 99.27
CPH-BCR 12 11.9 99.37 12 12.0 99.95
20 19.9 99. 59 20 19.9 99.39
25 25.1 100.32 25 24.8 99.35
CPH-CPR 15 14.9 99.66 15 15.1 100.53
20 19.9 99.66 20 19.9 99.41
25 25.1 100.30 25 24.9 99.42
CPH-CR 15 14.9 99.87 15 15.1 100.4
20 19.9 99.85 20 19.9 99.34
25 25.0 100.12 25 24.9 99.55
TFPH-AR 20 20.1 100.09 20 20.0 99.98
30 30.0 100.04 30 29.9 99.76
40 40.1 100.20 40 39.9 99.79
TFPH-BCP 12 12 100 12 11.9 99.55
20 20.0 99.97 20 19.9 99.45
25 25.0 100.02 25 25.0 100.16
TFPH-CPR 15 14.9 99.56 15 15.0 99.92
25 25.0 99.99 25 25.0 100.06
35 35.1 100.24 35 34.9 99.72
TFPH-CR 20 20.0 99.98 20 20.0 99.99
30 30.0 99.94 30 29.9 99.63
35 35.1 100.24 35 34.9 99.67
Table 3 Statistical treatment of data obtained for CPH and TFPH applying the proposed methods in comparison with the
Pharmacopeia method.
Parameters Pharmacopeia method AR BCP CPR CR
Pure solution (CPH)
X± SD 100.01 ± 0.19 99.97 ± 0.11 99.76 ± 0.22 99.86 ± 0.18 99.94 ± 0.14
N 4 5 5 5 5
Tablets (CPH)
X± SD 99.93 ± 0.21 99.71 ± 0.18 99.56 ± 0.26 100.09 ± 0.17 99.76 ± 0.21
n 4 5 5 5 5
Pure solution (TFPH)
X± SD 99.98 ± 0.12 100.11 ± 0.14 99.99 ± 0.38 99.93 ± 0.19 100.05 ± 0.20
n 4 5 5 5 5
Tablets TFPH
X± SD 99.95 ± 0.11 99.84 ± 0.11 99.72 ± 0.38 99.84 ± 0.11 99.76 ± 0.15
n 4 5 5 5 5
Theoretical value at 95% conﬁdence level.
n: Number of replicates.
66 M.E.M. Hassouna et al.3.1.6. Effect of sequence of addition
The optimum sequence of addition was (reagent–drug–buffer–
solvent). For production of the highest color intensity and
shortest time for maximum absorbance, while other sequences
needed longer time besides lower stability.3.2. The stoichiometry of the ion-pair
The stoichiometry of the ion-pair formed between the drugs
under investigation and cited reagents was investigated by
applying the continuous variation method21 and molar ratio
Table 4 Determination of CPH and TFPH in pharmaceutical preparations using the reagents AR, BCP, CPR and CR and
Pharmacopeia method.
R Drug Name of preparation (Drug) taken (lg/ml) Recovery (n= 4) t-test F-test
Proposed Pharmacopeia
AR CPH Promacid 20 19.9 19.8 1.59 8.10
30 30.2 30.1 1.14 4.81
40 39.7 39.8 1.80 1.40
TFPH Stellasile 20 20.0 20.1 2.95 2.00
30 30.0 29.9 2.67 2.22
40 39.9 39.9 2.77 4.67
BCP CPH Promacid 12 12.0 12.0 1.88 2.30
20 19.9 19.8 1.95 6.14
25 24.8 24.9 1.70 1.27
TFPH Stellasile 12 11.9 12.0 2.80 7.00
20 19. 9 20.1 2.63 5.55
25 25.0 25.0 1.94 1.63
CPR CPH Promacid 15 15.1 15.1 2.37 6.98
20 19.9 19.8 1.91 8.04
30 30.1 30.1 1.56 2.29
TFPH Stellasile 15 14.9 15.0 3.00 1.16
25 25.0 25.0 0.29 1.06
35 34.9 34.9 2.25 3.83
CR CPH Promacid 15 15.1 15.1 2.94 3.87
20 19.9 19.8 1.25 7.31
25 24. 9 30.1 0.85 1.09
TFPH Stellasile 20 20.0 20.1 2.22 1.22
30 29. 9 29.9 1.08 5.71
35 34.9 34.9 3.07 5.145
Tabulated t-value at 95% conﬁdence limit = 3.18 at degrees of freedom= 3. Tabulated F-value at 95% conﬁdence limit = 9.12.
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67method.22 The results indicate the existence of [1:1 drug:rea-
gent] charge transfer complex at the speciﬁed kmax (Figs. 7–10).
3.3. Interferences
No interference was observed in the determination of CPH and
TFPH with the studied reagents (AR, BCP, CPR and CR) in
the presence of different additives such as lactose, glycerol,
propylene glycol, sugar, sodium acetate and starch which are
usually present as ﬁllers and excipients in pharmaceutical
preparations.
3.4. Validation of the method
Results obtained were compared with those of the ofﬁcial
methods. The statistical treatment of obtained results revealed
that there is no signiﬁcant difference between the proposed
methods and ofﬁcial ones as shown in Tables 3 and 4. Five rep-
licate determinations at different concentration levels were car-
ried out to test the precision of the method. The overall
recoveries are in the range (99.27–100.53%) (Table 2), reﬂect-
ing high accuracy of the method, in addition to high precision
indicated by the low values of relative standard deviations. The
performance of the proposed method was assessed by calcula-
tion of (t) and (F) tests compared with the Pharmacopeias
method.23 Mean values were obtained with student’s (t) and
(F) tests at 95% conﬁdence level showed the absence of system-
atic errors in the method.4. Conclusions
The proposed methods for the estimation of CPH and TFPH
with different reagents (AR, BCP, CPR and CR) in pharma-
ceutical preparations was successfully applied to various dos-
age forms, the results are recorded in Table 1 compared
statistically with the ofﬁcial methods.23 High recoveries, accu-
racy, in addition to the high precision indicated by the low val-
ues of relative standard deviations24 have been achieved. The
four reagents gave comparable recoveries ,however the rela-
tively high values of the molar absorptivities of the ion pairs
of both drugs with BCP gives it some preferability over the
others. Also these methods are applicable to wide range of
concentrations, less time consuming and need simple appara-
tus and reagents which are available in every laboratory, thus
offering an economic method for routine determination of the
cited drugs.
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